Although it is not clear how Aqp5 sustains this ductal progenitor cell pool, our data suggest that activation of nuclear GSK-3β and KRasG12D within this pool of cells drives their retention and ultimately the development of IPMN lesions. The gene discussed is GSK3B; the disease is pancreatic intraductal papillary-mucinous neoplasm.